COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review.

Juan Ignacio RuizMaria A Lopez-OlivoYimin GengMaria E Suarez-Almazor

Published in: Journal of immunotherapy and precision oncology (2023)

Although current evidence is limited, COVID-19 clinical outcomes of patients with cancer receiving ICI therapy appear to be similar to those not receiving oncologic treatment or other cancer therapies.

Keyphrases

coronavirus disease
sars cov
papillary thyroid
type diabetes
squamous cell
rectal cancer
stem cells
metabolic syndrome
prostate cancer
replacement therapy
insulin resistance